Joanna Hlebowicz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Joanna Hlebowicz has a total of 147 co-authors. Here are the top co-authors by number of shared publications:
- Sandra Lindstedt
Department of Clinical Sciences, Lund University, Lund, Sweden
16 shared publications - Magnus Dencker
Department of Medical Imaging and Physiology Skåne University Hospital Malmö Sweden
7 shared publications - Ola Björgell
Department of Radiology, University of Lund, Malmö University Hospital, Malmö, Sweden
7 shared publications Bengt Johansson
Umeå University, Umeå, Sweden
4 shared publications- Gassan Darwiche
Department of Medicine, University of Lund, Malmö University Hospital, Malmö, Sweden
4 shared publications - Lars-Olof Almér
Department of Medicine, University of Lund, Malmö University Hospital, Malmö, Sweden
4 shared publications
Latest Publications
- Open Access
- 20 July 2026
- Published by Oxford University Press (OUP) in European Journal of Cardiovascular Nursing
- Vol. 25 (6) , 1261-1265
Distribution-based thresholds for clinically important differences in patient-reported outcomes for adults with congenital heart disease
- 20 July 2026
- Published by Oxford University Press (OUP) in European Journal of Cardiovascular Nursing
- Vol. 25 (6) , 1261-1265
Open AccessDistribution-based thresholds for clinically important differences in patient-reported outcomes for adults with congenital heart disease
- 18 May 2026
- Published by Wiley in Clinical Physiology and Functional Imaging
- Vol. 46 (3) , e70069
Effect of food intake on biomarkers measured by the Proseek Multiplex Metabolism panel
Food intake induces metabolic and hemodynamic changes, but its impact on many circulating protein biomarkers remains unclear. This study assessed the effect of a standardised meal on 85 plasma biomarkers measured by the Proseek Multiplex Metabolism panel. Twenty‐two healthy adults (11 men, 11 women; mean age 25.9 ± 4.2 years) were examined after an overnight fast and at 30 and 120 min following a standardised meal. Plasma samples were analysed with the Proseek Multiplex Metabolism panel. Twelve biomarkers decreased significantly after food intake; none increased. Eight biomarkers were reduced at 30 min, and four remained decreased at 120 min. The largest changes (>20%) were observed for DNA‐(apurinic/apyrimidinic site) endonuclease, eosinophil cationic protein, thyrotropin subunit beta, carbonic anhydrase 13, and Crk‐like protein. Food intake has modest effects on most biomarkers in the Proseek Multiplex Metabolism panel, suggesting fasting may not be critical for routine use. However, caution is warranted for biomarkers showing >20% change. Further studies in diverse populations and disease states are needed to confirm these findings.
- 18 May 2026
- Published by Wiley in Clinical Physiology and Functional Imaging
- Vol. 46 (3) , e70069
Effect of food intake on biomarkers measured by the Proseek Multiplex Metabolism panel
Food intake induces metabolic and hemodynamic changes, but its impact on many circulating protein biomarkers remains unclear. This study assessed the effect of a standardised meal on 85 plasma biomarkers measured by the Proseek Multiplex Metabolism panel. Twenty‐two healthy adults (11 men, 11 women; mean age 25.9 ± 4.2 years) were examined after an overnight fast and at 30 and 120 min following a standardised meal. Plasma samples were analysed with the Proseek Multiplex Metabolism panel. Twelve biomarkers decreased significantly after food intake; none increased. Eight biomarkers were reduced at 30 min, and four remained decreased at 120 min. The largest changes (>20%) were observed for DNA‐(apurinic/apyrimidinic site) endonuclease, eosinophil cationic protein, thyrotropin subunit beta, carbonic anhydrase 13, and Crk‐like protein. Food intake has modest effects on most biomarkers in the Proseek Multiplex Metabolism panel, suggesting fasting may not be critical for routine use. However, caution is warranted for biomarkers showing >20% change. Further studies in diverse populations and disease states are needed to confirm these findings.
- Open Access
- 11 May 2026
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 47 (29) , 3951-3961
Outcomes after a first acute myocardial infarction in patients with or without congenital heart disease
The life expectancy of adult patients with congenital heart disease (ACHD) has improved, thus shifting the research focus towards age-related comorbidities to continue to improve patient outcomes. This study aimed to investigate all-cause mortality and recurrent acute myocardial infarction (AMI) in adults with and without congenital heart disease. A nationwide case control study was conducted between 2000 and 2022. Patients with ACHD (n = 214) and controls (n = 275 377) who experienced their first AMI were identified. Of these, each patient (n = 213) with ACHD was matched with 10 controls (n = 2092) based on age, sex, hypertension, diabetes, hyperlipidaemia, and history of percutaneous coronary intervention or coronary artery bypass grafting. Mortality and recurrent AMI were assessed using unadjusted and adjusted Cox regression for matching and other clinical covariates. Patients with ACHD were younger (58 ± 14 years) than controls (70 ± 12 years) before the matching (P < .001). The mean follow-up time was 6.5 and 7.3 years for patients with ACHD and controls, respectively. There was no significant difference in mortality or recurrent AMI rates at 1 year between patients with ACHD and matched controls. The mortality rate was higher in ACHD at 10 years of follow-up (hazard ratio 1.4, 95% confidence interval 1.0–1.9) but did not remain after adjustment. This study suggests that survival rates and the incidence of recurrent AMI in ACHD patients are similar to those of controls. Since patients with ACHD share similar cardiovascular risk factors as the general population, promoting healthy lifestyles and proactive risk management is crucial to mitigate acquired heart disease. Flowchart showing the inclusion of all patients aged ≥18 years who had their first-time acute myocardial infarction (AMI) recorded in SWEDEHEART between 1 January 2000 and 2 February 2022. Cumulative risk of first AMI in 214 patients with adult congenital heart disease (ACHD) and 257,377 controls (Log rank < 0.05). Kaplan-Meier survival graph of mortality in 213 patients with ACHD and 2,092 matched controls who had an AMI between 2000 and 2022 (Log rank p = 0.81).
- 11 May 2026
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 47 (29) , 3951-3961
Open AccessOutcomes after a first acute myocardial infarction in patients with or without congenital heart disease
The life expectancy of adult patients with congenital heart disease (ACHD) has improved, thus shifting the research focus towards age-related comorbidities to continue to improve patient outcomes. This study aimed to investigate all-cause mortality and recurrent acute myocardial infarction (AMI) in adults with and without congenital heart disease. A nationwide case control study was conducted between 2000 and 2022. Patients with ACHD (n = 214) and controls (n = 275 377) who experienced their first AMI were identified. Of these, each patient (n = 213) with ACHD was matched with 10 controls (n = 2092) based on age, sex, hypertension, diabetes, hyperlipidaemia, and history of percutaneous coronary intervention or coronary artery bypass grafting. Mortality and recurrent AMI were assessed using unadjusted and adjusted Cox regression for matching and other clinical covariates. Patients with ACHD were younger (58 ± 14 years) than controls (70 ± 12 years) before the matching (P < .001). The mean follow-up time was 6.5 and 7.3 years for patients with ACHD and controls, respectively. There was no significant difference in mortality or recurrent AMI rates at 1 year between patients with ACHD and matched controls. The mortality rate was higher in ACHD at 10 years of follow-up (hazard ratio 1.4, 95% confidence interval 1.0–1.9) but did not remain after adjustment. This study suggests that survival rates and the incidence of recurrent AMI in ACHD patients are similar to those of controls. Since patients with ACHD share similar cardiovascular risk factors as the general population, promoting healthy lifestyles and proactive risk management is crucial to mitigate acquired heart disease. Flowchart showing the inclusion of all patients aged ≥18 years who had their first-time acute myocardial infarction (AMI) recorded in SWEDEHEART between 1 January 2000 and 2 February 2022. Cumulative risk of first AMI in 214 patients with adult congenital heart disease (ACHD) and 257,377 controls (Log rank < 0.05). Kaplan-Meier survival graph of mortality in 213 patients with ACHD and 2,092 matched controls who had an AMI between 2000 and 2022 (Log rank p = 0.81).
- Open Access
- 17 April 2026
- Published by BMJ in Open Heart
- Vol. 13 (1) , e003782
Long-term outcome in adults with a previous Ross operation: a cohort study
Introduction: In aortic valve disease, several interventions are available. In young people who are still growing, or considering the risks of long-term anticoagulation, the Ross procedure remains an alternative for aortic valve replacement. This procedure entails the transposition of the patient’s pulmonary valve to the aortic position, with placement of a homograft in the pulmonary position. However, long-term prognosis remains largely unknown. Methods: The Swedish national registry of congenital heart disease was searched for adult patients with a history of Ross operation. Results: 82 patients (mean age 40.4±15.8 years) were identified, with a mean age at the time of the Ross procedure of 23.6±14.7 years. After a mean follow-up of 16.8±5.5 years, 24.4% of patients underwent a first reoperation involving either the neoaortic valve or the pulmonary homograft, at a mean age of 32.0±13.9 years. The cumulative incidence of reoperation was approximately 15% at 10 years and 30% at 20 years post-Ross procedure. Among the 20 reinterventions, 17 (85.0%) involved the pulmonary valve and 8 the neoaortic valve; five patients underwent procedures on both valves. Two patients (2.3%) died during follow-up. Forty-eight patients in the cohort had undergone primary Ross surgery. This subgroup was older at the time of data extraction (mean age 46.7±15.7 years) compared with those who underwent secondary Ross surgery (mean age 31.3±10.7 years), that is, typically following previous interventions. The secondary Ross group demonstrated better left ventricular function, with ejection fraction >50% in 91.7% of cases, compared with 69.8% in the primary group (p=0.041). Conclusion: One in four patients undergoing the Ross procedure requires a reintervention, commonly involving the pulmonary valve. Long-term mortality was low. In selected patients, the Ross procedure remains a viable option; however, late morbidity must be considered. Our findings suggest that secondary Ross surgery is associated with better long-term outcomes, particularly regarding left ventricular function, although the underlying mechanisms remain unclear.
- 17 April 2026
- Published by BMJ in Open Heart
- Vol. 13 (1) , e003782
Open AccessLong-term outcome in adults with a previous Ross operation: a cohort study
Introduction: In aortic valve disease, several interventions are available. In young people who are still growing, or considering the risks of long-term anticoagulation, the Ross procedure remains an alternative for aortic valve replacement. This procedure entails the transposition of the patient’s pulmonary valve to the aortic position, with placement of a homograft in the pulmonary position. However, long-term prognosis remains largely unknown. Methods: The Swedish national registry of congenital heart disease was searched for adult patients with a history of Ross operation. Results: 82 patients (mean age 40.4±15.8 years) were identified, with a mean age at the time of the Ross procedure of 23.6±14.7 years. After a mean follow-up of 16.8±5.5 years, 24.4% of patients underwent a first reoperation involving either the neoaortic valve or the pulmonary homograft, at a mean age of 32.0±13.9 years. The cumulative incidence of reoperation was approximately 15% at 10 years and 30% at 20 years post-Ross procedure. Among the 20 reinterventions, 17 (85.0%) involved the pulmonary valve and 8 the neoaortic valve; five patients underwent procedures on both valves. Two patients (2.3%) died during follow-up. Forty-eight patients in the cohort had undergone primary Ross surgery. This subgroup was older at the time of data extraction (mean age 46.7±15.7 years) compared with those who underwent secondary Ross surgery (mean age 31.3±10.7 years), that is, typically following previous interventions. The secondary Ross group demonstrated better left ventricular function, with ejection fraction >50% in 91.7% of cases, compared with 69.8% in the primary group (p=0.041). Conclusion: One in four patients undergoing the Ross procedure requires a reintervention, commonly involving the pulmonary valve. Long-term mortality was low. In selected patients, the Ross procedure remains a viable option; however, late morbidity must be considered. Our findings suggest that secondary Ross surgery is associated with better long-term outcomes, particularly regarding left ventricular function, although the underlying mechanisms remain unclear.
- Open Access
- 14 November 2025
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 105 (1) , 7-17
Obstetric outcome in women with congenital heart disease: A nationwide cohort in Sweden
Introduction: Survival and healthcare for patients with congenital heart disease have improved, and the number of pregnancies among women of childbearing age with congenital heart disease has increased. Our aim was to investigate obstetric outcomes in a large retrospective, national registry study of women with congenital heart disease compared to controls. Material and Methods: The study included women over 18 years of age from the Swedish Registry of Congenital Heart Disease. Each case was matched with 10 controls from Statistics Sweden, based on the mother's birth year and birth county and all were subsequently linked to the Swedish Medical Birth Register. We included 7998 pregnancies in women with congenital heart disease and 84 799 in controls during 1973–2020. Results: The mean age at delivery for women with congenital heart disease and controls was 28.7 (±5.0) and 28.7 (±5.1) years, respectively. Women with congenital heart disease smoked less, had a shorter gestation and a higher incidence of delivery by Cesarean section compared to controls. The likelihood of Cesarean section was increased in women with congenital heart disease compared to controls: odds ratio 1.45 (95% confidence interval (CI) 1.37–1.54). Compared to controls, women with congenital heart disease had an increased likelihood of giving birth to small‐for‐gestational‐age neonates: odds ratio 1.40 (95% CI 1.23–1.58). The association regarding small‐for‐gestational‐age remained after adjusting for body mass index, age, smoking, comorbid diseases and preeclampsia. Women with congenital heart disease had an increased likelihood of prematurity compared to controls: odds ratio 1.47 (95% CI 1.35–1.59). The likelihood of Cesarean section, small‐for‐gestational‐age neonates and prematurity was higher in women with severe congenital heart disease than mild/moderate congenital heart disease, both compared to controls. Conclusions: In this large national case–control study in women with congenital heart disease, we showed an increased likelihood of giving birth prematurely by Cesarean section, and having a small‐for‐gestational‐age neonate compared to matched controls. The likelihood seems even higher in women with severe congenital heart disease. Further research is needed to explore the underlying reasons for the high rates of Cesarean section in women with congenital heart disease.
- 14 November 2025
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 105 (1) , 7-17
Open AccessObstetric outcome in women with congenital heart disease: A nationwide cohort in Sweden
Introduction: Survival and healthcare for patients with congenital heart disease have improved, and the number of pregnancies among women of childbearing age with congenital heart disease has increased. Our aim was to investigate obstetric outcomes in a large retrospective, national registry study of women with congenital heart disease compared to controls. Material and Methods: The study included women over 18 years of age from the Swedish Registry of Congenital Heart Disease. Each case was matched with 10 controls from Statistics Sweden, based on the mother's birth year and birth county and all were subsequently linked to the Swedish Medical Birth Register. We included 7998 pregnancies in women with congenital heart disease and 84 799 in controls during 1973–2020. Results: The mean age at delivery for women with congenital heart disease and controls was 28.7 (±5.0) and 28.7 (±5.1) years, respectively. Women with congenital heart disease smoked less, had a shorter gestation and a higher incidence of delivery by Cesarean section compared to controls. The likelihood of Cesarean section was increased in women with congenital heart disease compared to controls: odds ratio 1.45 (95% confidence interval (CI) 1.37–1.54). Compared to controls, women with congenital heart disease had an increased likelihood of giving birth to small‐for‐gestational‐age neonates: odds ratio 1.40 (95% CI 1.23–1.58). The association regarding small‐for‐gestational‐age remained after adjusting for body mass index, age, smoking, comorbid diseases and preeclampsia. Women with congenital heart disease had an increased likelihood of prematurity compared to controls: odds ratio 1.47 (95% CI 1.35–1.59). The likelihood of Cesarean section, small‐for‐gestational‐age neonates and prematurity was higher in women with severe congenital heart disease than mild/moderate congenital heart disease, both compared to controls. Conclusions: In this large national case–control study in women with congenital heart disease, we showed an increased likelihood of giving birth prematurely by Cesarean section, and having a small‐for‐gestational‐age neonate compared to matched controls. The likelihood seems even higher in women with severe congenital heart disease. Further research is needed to explore the underlying reasons for the high rates of Cesarean section in women with congenital heart disease.
- Open Access
- 21 October 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (20) , e040253
Risk Factors for Reintervention Following Treatment for Aortic Coarctation With or Without Aortic Arch Hypoplasia in Sweden: From Isolated Coarctation to Complex Bi‐ and Univentricular Congenital Heart Disease
Background: Repaired coarctation of the aorta (CoA)—either simple or as part of complex congenital heart disease—can be associated with long‐term sequelae such as recoarctation of the aorta (reCoA) or arterial hypertension. The aim of this study was to determine the prevalence and risk factors for requiring reintervention for reCoA in patients with simple as well as complex bi‐ and univentricular types of congenital heart disease. Methods: Data on patients with a diagnosis of CoA were retrieved from the SWEDCON (Swedish National Registry of Congenital Heart Disease) from 1973 to 2020. Surgically and catheter‐based repaired CoA were analyzed separately. Results: The study included 1609 children and adults with surgically repaired CoA and 170 with catheter‐based CoA intervention. A total of 249 (15%) of the patients after surgically repaired CoA and 59 (35%) after catheter‐based repaired CoA received interventions for reCoA. The risk of aortic reintervention following primary surgical CoA repair was increased in patients with complex biventricular and univentricular congenital heart disease. Use of patch augmentation and aortic arch reconstruction through Norwood procedure were associated with increased risk of reCoA, whereas end‐to‐end or end‐to‐side anastomosis were associated with a decreased risk of reCoA. Younger age at primary surgical CoA repair was associated with increased risk of reCoA. Overall, a high prevalence of hypertension was observed. Conclusions: Our study shows for the first time that patients with univentricular and biventricular complex CHD and those following patch aortoplasty or single ventricle palliation with Norwood surgery are at a higher risk for reintervention at the CoA site after surgical repair than patients with uncomplicated CoA.
- 21 October 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (20) , e040253
Open AccessRisk Factors for Reintervention Following Treatment for Aortic Coarctation With or Without Aortic Arch Hypoplasia in Sweden: From Isolated Coarctation to Complex Bi‐ and Univentricular Congenital Heart Disease
Background: Repaired coarctation of the aorta (CoA)—either simple or as part of complex congenital heart disease—can be associated with long‐term sequelae such as recoarctation of the aorta (reCoA) or arterial hypertension. The aim of this study was to determine the prevalence and risk factors for requiring reintervention for reCoA in patients with simple as well as complex bi‐ and univentricular types of congenital heart disease. Methods: Data on patients with a diagnosis of CoA were retrieved from the SWEDCON (Swedish National Registry of Congenital Heart Disease) from 1973 to 2020. Surgically and catheter‐based repaired CoA were analyzed separately. Results: The study included 1609 children and adults with surgically repaired CoA and 170 with catheter‐based CoA intervention. A total of 249 (15%) of the patients after surgically repaired CoA and 59 (35%) after catheter‐based repaired CoA received interventions for reCoA. The risk of aortic reintervention following primary surgical CoA repair was increased in patients with complex biventricular and univentricular congenital heart disease. Use of patch augmentation and aortic arch reconstruction through Norwood procedure were associated with increased risk of reCoA, whereas end‐to‐end or end‐to‐side anastomosis were associated with a decreased risk of reCoA. Younger age at primary surgical CoA repair was associated with increased risk of reCoA. Overall, a high prevalence of hypertension was observed. Conclusions: Our study shows for the first time that patients with univentricular and biventricular complex CHD and those following patch aortoplasty or single ventricle palliation with Norwood surgery are at a higher risk for reintervention at the CoA site after surgical repair than patients with uncomplicated CoA.
- Open Access
- 15 August 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (16) , 5783
Effect of Food Intake on Vortex Formation Time as a Measurement of Diastolic Left Ventricular Function
Objectives: The aim of the present study was to assess if vortex formation time (VFT) as a measurement of left ventricular (LV) diastolic function is affected by food intake and related to age and sex. Methods: Healthy participants were divided into two age groups: younger (median age: 25 years) and older (median age: 68 years). Transthoracic echocardiography (TTE) examinations were performed during fasting as well as 30 min after a standardized meal. Measurements of the TTE images were performed off-line for the calculation of VFT. Results: There were no differences in VFT between men and women regardless of age. There was a significant increase in VFT from a median value of 2.0 (1.5–2.5) to a median value of 2.3 (1.5–2.0) after food intake in the older study group (p < 0.001). This was not observed in the younger study group, which had a median value of VFT of 2.5 (2.1–3.0) before food intake and a median value of VFT of 2.5 (2.2–3.1) after food intake (p = 0.369). Furthermore, VFT was significantly higher in the younger study group, i.e., 2.5 (2.1–3.0), compared to the older study group, i.e., 2.0 (1.5–2.5), before food intake (p = 0.011), but not after food intake, with a median value of VFT in the younger group of 2.5 (2.2–3.1) and the older group of 2.3 (1.5–2.9) (p = 0.172). Conclusions: Our findings suggest that VFT is affected by age, not by sex. Moreover, VFT is affected by food intake only in elderly subjects.
- 15 August 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (16) , 5783
Open AccessEffect of Food Intake on Vortex Formation Time as a Measurement of Diastolic Left Ventricular Function
Objectives: The aim of the present study was to assess if vortex formation time (VFT) as a measurement of left ventricular (LV) diastolic function is affected by food intake and related to age and sex. Methods: Healthy participants were divided into two age groups: younger (median age: 25 years) and older (median age: 68 years). Transthoracic echocardiography (TTE) examinations were performed during fasting as well as 30 min after a standardized meal. Measurements of the TTE images were performed off-line for the calculation of VFT. Results: There were no differences in VFT between men and women regardless of age. There was a significant increase in VFT from a median value of 2.0 (1.5–2.5) to a median value of 2.3 (1.5–2.0) after food intake in the older study group (p < 0.001). This was not observed in the younger study group, which had a median value of VFT of 2.5 (2.1–3.0) before food intake and a median value of VFT of 2.5 (2.2–3.1) after food intake (p = 0.369). Furthermore, VFT was significantly higher in the younger study group, i.e., 2.5 (2.1–3.0), compared to the older study group, i.e., 2.0 (1.5–2.5), before food intake (p = 0.011), but not after food intake, with a median value of VFT in the younger group of 2.5 (2.2–3.1) and the older group of 2.3 (1.5–2.9) (p = 0.172). Conclusions: Our findings suggest that VFT is affected by age, not by sex. Moreover, VFT is affected by food intake only in elderly subjects.
- Open Access
- 16 June 2025
- Published by Elsevier in International Journal of Cardiology Congenital Heart Disease
- Vol. 21, 100601
Fatigue in adults with congenital heart disease aged over 40 years
- 16 June 2025
- Published by Elsevier in International Journal of Cardiology Congenital Heart Disease
- Vol. 21, 100601
Open AccessFatigue in adults with congenital heart disease aged over 40 years
- Open Access
- 11 March 2024
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 34 (7) , 1-7
Electrocardiographic proarrhythmic changes in pregnancy of women with CHD
Objectives:Pregnancy-related physiological adaptations result in increased heart rate as well as electrocardiographic changes such as a mean QTc prolongation of 27 ms. Pregnant women with CHD are at increased risk for cardiovascular complications. The aim of this study was to identify risk factors for abnormally prolonged QTc interval—a risk factor for ventricular arrhythmias—in pregnant women with CHD.Material and method:Retrospective longitudinal single-centre study. Pre-pregnancy demographic and electrocardiographic risk factors for abnormal QTc duration during pregnancy of (a) > 460 ms and (b) >27 ms increase were analyzed.Results:Eighty-three pregnancies in 63 women were included, of which three had documented arrhythmias. All five Modified World Health Organization Classification of Maternal Cardiovascular Risk (mWHO) classes were represented, with 15 pregnancies (18.1%) in mWHO class I, 26 (31.3%) in mWHO II, 28 (33.7%) in mWHO II-III, 11 (13.3%) in mWHO III, and three pregnancies (3.6%) in mWHO class IV. Heart rate and QTc interval increased, while QRS duration and PR interval shortened during pregnancy. QTc duration of > 460 ms was associated with increased pre-pregnancy QTc interval, QRS duration, and weight, as well as body mass index. QTc increase of > 27 ms was associated with increased heart rate prior to pregnancy. No significant associations of electrocardiographic changes with mWHO class or CHD type were identified.Conclusion:Increased QTc in pregnant women with CHD was associated with being overweight or having higher heart rate, QRS, or QTc duration prior to pregnancy. These patients should be monitored closely for arrhythmias during pregnancy.
- 11 March 2024
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 34 (7) , 1-7
Open AccessElectrocardiographic proarrhythmic changes in pregnancy of women with CHD
Objectives:Pregnancy-related physiological adaptations result in increased heart rate as well as electrocardiographic changes such as a mean QTc prolongation of 27 ms. Pregnant women with CHD are at increased risk for cardiovascular complications. The aim of this study was to identify risk factors for abnormally prolonged QTc interval—a risk factor for ventricular arrhythmias—in pregnant women with CHD.Material and method:Retrospective longitudinal single-centre study. Pre-pregnancy demographic and electrocardiographic risk factors for abnormal QTc duration during pregnancy of (a) > 460 ms and (b) >27 ms increase were analyzed.Results:Eighty-three pregnancies in 63 women were included, of which three had documented arrhythmias. All five Modified World Health Organization Classification of Maternal Cardiovascular Risk (mWHO) classes were represented, with 15 pregnancies (18.1%) in mWHO class I, 26 (31.3%) in mWHO II, 28 (33.7%) in mWHO II-III, 11 (13.3%) in mWHO III, and three pregnancies (3.6%) in mWHO class IV. Heart rate and QTc interval increased, while QRS duration and PR interval shortened during pregnancy. QTc duration of > 460 ms was associated with increased pre-pregnancy QTc interval, QRS duration, and weight, as well as body mass index. QTc increase of > 27 ms was associated with increased heart rate prior to pregnancy. No significant associations of electrocardiographic changes with mWHO class or CHD type were identified.Conclusion:Increased QTc in pregnant women with CHD was associated with being overweight or having higher heart rate, QRS, or QTc duration prior to pregnancy. These patients should be monitored closely for arrhythmias during pregnancy.
- Open Access
- 3 May 2023
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 34 (1) , 18-23
Self-reported quality of life before, during, and after pregnancy in women with CHD
Background: Adults with CHD are a growing patient group and childbirth is a relatively new phenomenon. EQ-5D is commonly used to measure health-related quality of life. We sought to investigate EQ-5D status before, during, and after pregnancy in women with CHD.Methods: We identified 128 pregnancies in 86 CHD women giving birth in Skåne County during 2009–2021. Repeated measures ANOVA was performed to test for differences between the five EQ-5D domains, EQ-VAS, and EQ-index over time points before, the second trimester, the third trimester, and after pregnancy.Results: Mean age at estimated childbirth was 30.3 (± 4.7) years; 56.25% of births were vaginal deliveries and 43.75% were Caesarean sections. The cohort consisted of patients with double outlet right ventricle (4.7%), transposition (Mustard/Senning 2.3%, arterial switch 4.7%), aortic anomalies (19.5%), Fallot’s anomaly (16.4%), single ventricle (3.9%), shunt lesions (11.7%), cardiomyopathies (4.7%), coronary anomalies (1.6%), arrythmias (0.8%), and valve lesions: aortic (19.5%), mitral (5.5%), and pulmonary (4.7%). The women reported significantly worse mobility (p = 0.007) and higher pain/discomfort (p = 0.049) at trimester 3 compared to before pregnancy. The women had lower EQ-5D index during trimester 3 compared to after pregnancy (p = 0.004). We saw worse mobility during Tri 2 comparing multiparity with primiparity (p = 0.046). Looking at delivery mode, we noted significantly higher anxiety/depression before pregnancy (p =0.023) in women that had a Caesarean section.Conclusions: In this study, women with CHD reported worse mobility and a higher pain level during Tri 3, although the overall health-related quality of life is acceptably high.
- 3 May 2023
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 34 (1) , 18-23
Open AccessSelf-reported quality of life before, during, and after pregnancy in women with CHD
Background: Adults with CHD are a growing patient group and childbirth is a relatively new phenomenon. EQ-5D is commonly used to measure health-related quality of life. We sought to investigate EQ-5D status before, during, and after pregnancy in women with CHD.Methods: We identified 128 pregnancies in 86 CHD women giving birth in Skåne County during 2009–2021. Repeated measures ANOVA was performed to test for differences between the five EQ-5D domains, EQ-VAS, and EQ-index over time points before, the second trimester, the third trimester, and after pregnancy.Results: Mean age at estimated childbirth was 30.3 (± 4.7) years; 56.25% of births were vaginal deliveries and 43.75% were Caesarean sections. The cohort consisted of patients with double outlet right ventricle (4.7%), transposition (Mustard/Senning 2.3%, arterial switch 4.7%), aortic anomalies (19.5%), Fallot’s anomaly (16.4%), single ventricle (3.9%), shunt lesions (11.7%), cardiomyopathies (4.7%), coronary anomalies (1.6%), arrythmias (0.8%), and valve lesions: aortic (19.5%), mitral (5.5%), and pulmonary (4.7%). The women reported significantly worse mobility (p = 0.007) and higher pain/discomfort (p = 0.049) at trimester 3 compared to before pregnancy. The women had lower EQ-5D index during trimester 3 compared to after pregnancy (p = 0.004). We saw worse mobility during Tri 2 comparing multiparity with primiparity (p = 0.046). Looking at delivery mode, we noted significantly higher anxiety/depression before pregnancy (p =0.023) in women that had a Caesarean section.Conclusions: In this study, women with CHD reported worse mobility and a higher pain level during Tri 3, although the overall health-related quality of life is acceptably high.